Count | |
| 27 | |
| 8 | |
| 8 | |
| 1 | |
| 1 | |
| 3 | |
| 1 | |
| 1 | |
| 1 | |
Cardiopulmonary Bypass/adverse effects/instrumentation/*methods | 1 |
Cardiopulmonary Bypass/*adverse effects/statistics & numerical data | 1 |
| 46 | |
| 92 | |
| 3 | |
| 8 | |
| 13 | |
| 1 | |
| 1 | |
| 1 | |
| 3 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 3 | |
| 1 | |
| 4 | |
| 12 | |
| 1 | |
| 2 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 4 | |
| 5 | |
| 3 | |
| 1 | |
| 4 | |
| 2 | |
| 2 | |
| 3 | |
| 57 | |
| 1 | |
| 74 | |
| 1 | |
| 6 | |
| 1 | |
| 8 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 3 | |
Arginine/adverse effects/*analogs & derivatives/blood/*drug effects | 1 |
Phosphoproteins/adverse effects/*antagonists & inhibitors/drug effects | 1 |
C-Reactive Protein/adverse effects/*drug effects/*metabolism | 1 |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 6 | |
| 2 | |
| 2 | |
| 1 | |
| 1 | |
| 4 | |
| 1 | |
| 2 | |
| 1 | |
| 2 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 3 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 3 | |